CFAP97

Across TCGA pan-cancer cohorts, CFAP97 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated CFAP97 data layer compared with 26 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher CFAP97 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CFAP97 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and HNSC show a favorable association.

PDAC, CCRCC, and LSCC are the cancer types where CFAP97 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.346	0.625	.003	25	view →
CCRCC	DFS	Median	All	1.000	0.733	.020	7	view →
LSCC	DFS	Median	All	0.448	0.873	.016	5	view →
HNSC	DFS	Median	All	0.988	0.916	.025	4	view →
LUAD	DFS	Median	III,IV	0.349	0.738	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

CFAP97–PDAC (DFS)

Open the PDAC breakdown →